Founded in 2003, Amyris Biotech is a company dedicated to bringing renewable diesel fuel to the public. Hoping to go public by 2011-12, Amyris Biotech deals in lower carbon-content, lab-created carbon fuels. By applying man-made molecular sciences to products and services, Amyris Biotech (headed by CEO John Melo) hopes to bring a renewable and much-needed solution to a few of the world’s biggest problems.
Amyris has already had some significant success in the work that they have done in reducing the cost of curing malaria – a disease that kills around 781,000 people a year, a figure equating to 2.23% of all annual deaths worldwide. Amyris is helping to produce cheaper and more effective synthetic pyridoxal-amino acid adducts – an artificial way of trapping the malaria parasites by injection into the system without harming the human body.
Of course, the main thing that we are interested in is the renewable diesel fuel! We all know that the fuel we use is a finite resource – whether it is petrol or gasoline (which are running out the world over and steadily rising in price) or diesel. Biodiesel is a man-made product, but one which uses alternative methods of production that do not involve fossil fuels. Rather, the preferable choice du jour seems to be to use biogas to create the liquid diesel. Biogas mainly comes from landfill – thus making new fuel from our rubbish dumps. This synthetic, non-petroleum based diesel is low in sulphur contents – a very good idea because while it is true that emissions from a diesel-powered engine are inherently bad for your health, with a diesel particulate filter these risks are almost completely negated.
Amyris is concentrating on replicating the hydrocarbons that are found in petroleum. By replicating rather than introducing a completely new product, Amyris ensures that companies will be able to keep to the same outlay costs as they currently have because their equipment would not have to be changed to deal with a differently-shaped element.
John Melo has gone from being president of U.S. fuels for BP to searching for a renewable solution to our problems. Not only that, but he has also focused his company’s efforts into curing malaria – a disease that everyone has heard of and most think is incurable. It is clear that Amyris Biotech is going to be a company to watch over the next couple of years.
Posted under Articles, Companies, Corporate, Product Innovations, Renewable Energy
This post was written by Katherine Quinn on April 11, 2011
-->
















